Cargando…

Cost-effectiveness of different human papillomavirus vaccines in Singapore

BACKGROUND: Human papillomavirus (HPV) vaccines are widely available and there have been studies exploring their potential clinical impact and cost-effectiveness. However, few studies have compared the cost-effectiveness among the 2 main vaccines available - a bivalent vaccine against HPV 16/18, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Vernon J, Tay, Sun Kuie, Teoh, Yee Leong, Tok, Mei Yin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082243/ https://www.ncbi.nlm.nih.gov/pubmed/21453537 http://dx.doi.org/10.1186/1471-2458-11-203

Ejemplares similares

Economic Analysis of Pandemic Influenza Vaccination Strategies in Singapore
por: Lee, Vernon J., et al.
Publicado: (2009)

Economic Impact of Dengue Illness and the Cost-Effectiveness of Future Vaccination Programs in Singapore
por: Carrasco, Luis R., et al.
Publicado: (2011)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Cost Effectiveness of a Potential Vaccine for Human papillomavirus
por: Sanders, Gillian D., et al.
Publicado: (2003)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Costs of delivering human papillomavirus vaccination in Tanzania
por: Struckmann, V, et al.
Publicado: (2022)

Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in Malaysia
por: Kriekinge, Georges Van, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2019)

Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience
por: Vijayalakshmi, Karuppiah, et al.
Publicado: (2022)

Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
por: Liu, Pang-Hsiang, et al.
Publicado: (2010)

Cost of a human papillomavirus vaccination project, Zimbabwe
por: Hidle, Anna, et al.
Publicado: (2018)

Safety and cost savings of reducing adult dengue hospitalization in a tertiary care hospital in Singapore
por: Lee, Linda K., et al.
Publicado: (2013)

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2021)

A case of imported Monkeypox in Singapore
por: Ng, Oon Tek, et al.
Publicado: (2019)

Medical ethics principles underscore advocating for human papillomavirus vaccine
por: Healy, C. Mary, et al.
Publicado: (2022)

Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
por: Liu, Yi-Jun, et al.
Publicado: (2016)

Health-seeking behavior of COVID-19 cases during the first eight weeks of the outbreak in Singapore: differences between local community and imported cases and having visits to single or multiple healthcare providers
por: Tay, Min Zhi, et al.
Publicado: (2022)

Gender and Sexual Orientation Differences in Human Papillomavirus (HPV) Vaccine Uptake among Chinese Young Adults
por: Choi, Edmond Pui Hang, et al.
Publicado: (2018)

Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine
por: Turner, Hugo C., et al.
Publicado: (2013)

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania
por: Quentin, Wilm, et al.
Publicado: (2012)

Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries
por: Kiatpongsan, Sorapop, et al.
Publicado: (2014)

Efficacy, patterns of use and cost of Pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: The National Cancer Centre Singapore experience
por: Rahardja, Sylwan, et al.
Publicado: (2020)

Ethnic differences in human papillomavirus awareness and vaccine acceptability
por: Marlow, L A V, et al.
Publicado: (2009)

Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
por: Cheng, Li-Jen, et al.
Publicado: (2021)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
por: Shi, Wenchuan, et al.
Publicado: (2021)

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
por: Kiendrébéogo, Joël Arthur, et al.
Publicado: (2023)

Healthcare workers in Singapore infected with COVID‐19: 23 January‐17 April 2020
por: Wong, Lai Yin, et al.
Publicado: (2020)

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore
por: Lee, Vernon J., et al.
Publicado: (2006)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule
por: Germar, Maria Julieta, et al.
Publicado: (2017)

Prevalence of Cataract Surgery and Visual Outcomes in Indian Immigrants in Singapore: The Singapore Indian Eye Study
por: Gupta, Preeti, et al.
Publicado: (2013)

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
por: Lim, Fong Seng, et al.
Publicado: (2014)

Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
por: Li, Xiao, et al.
Publicado: (2015)

Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
por: Mo, Xiuting, et al.
Publicado: (2017)

Human papillomavirus vaccination: the population impact
por: Lee, Lai-yang, et al.
Publicado: (2017)

Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
por: Simoens, Steven, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_56qe8me5d40nei8rfor2ei94cc